In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Bill Newell, CEO of Sutro Biopharma. Bill shared his views on the fundamental importance of ensuring patients, especially cancer patients, receive their treatment (as scheduled) despite pandemic related delays. He explained how they were uniquely positioned to continue trials and initial new ones safely and with minimal interruption due in large part to their onsite manufacturing facilities. Mike and Bill talked about how Sutro Biopharma successfully raised $98 million in a public offering through zoom calls which pre-pandemic would have been unheard of! They also explored the interesting dynamic they recently found themselves in when one of their major partners was acquired by another.  Hosted on Acast. See acast.com/privacy for more information.